PTN - Palatin Technologies Inc.
Close
1.63
0.060 3.681%
Share volume: 61,883
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.57
0.06
3.82%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 2022-09-22 | 2022-11-14 | 2023-02-14 | 2023-05-15 | 2023-09-28 | 2023-11-14 | 2024-02-14 | 2024-05-15 | |
Assets | |||||||||
Total Assets | 36.071 M | 27.642 M | 31.977 M | 25.609 M | 17.939 M | 11.247 M | 13.555 M | 11.406 M | |
Current Assets | 34.596 M | 26.177 M | 30.551 M | 24.239 M | 16.322 M | 9.805 M | 12.245 M | 10.269 M | |
Inventories | 944.471 K | 857.975 K | 759.268 K | 630.033 K | 526.000 K | 1.598 M | 0.000 | 0.000 | |
Other Current Assets | 1.932 M | 2.105 M | 2.127 M | 2.277 M | 1.897 M | 1.334 M | 413.954 K | 254.554 K | |
Short Term Investments | 1.932 M | 2.105 M | 2.127 M | 2.277 M | 1.897 M | 1.334 M | 413.954 K | 254.554 K | |
Total Receivables | 1.780 M | 2.023 M | 6.482 M | 1.699 M | 2.916 M | 1.349 M | 2.346 M | 0.000 | |
Current Cash | 29.939 M | 21.192 M | 21.183 M | 19.632 M | 10.982 M | 5.525 M | 9.485 M | 10.014 M | |
Total Non-current Assets | 1.475 M | 1.465 M | 1.425 M | 1.370 M | 1.618 M | 1.442 M | 1.309 M | 1.138 M | |
Property Plant Equipment | 539.314 K | 620.917 K | 674.567 K | 713.567 K | 684.910 K | 597.553 K | 550.465 K | 465.410 K | |
Other Assets | 56.916 K | 56.916 K | 56.916 K | 56.916 K | 56.916 K | 56.916 K | 56.916 K | 56.916 K | |
Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 36.071 M | 27.642 M | 31.977 M | 25.609 M | 17.939 M | 11.247 M | 13.555 M | 11.406 M | |
Total liabilities | 19.803 M | 19.193 M | 15.633 M | 16.016 M | 17.805 M | 16.136 M | 24.939 M | 9.827 M | |
Total current liabilities | 16.260 M | 15.861 M | 11.420 M | 11.851 M | 15.132 M | 13.610 M | 11.199 M | 8.533 M | |
Accounts Payable | 3.158 M | 3.774 M | 820.304 K | 2.786 M | 4.304 M | 2.270 M | 1.593 M | 3.443 M | |
Other liabilities | 2.861 M | 2.740 M | 3.733 M | 3.771 M | 2.083 M | 2.027 M | 13.382 M | 1.032 M | |
Current long term debt | 100.921 K | 102.264 K | 103.622 K | 104.998 K | 106.392 K | 107.805 K | 99.912 K | 73.141 K | |
Long term debt | 152.407 K | 126.333 K | 99.912 K | 73.141 K | 46.014 K | 18.527 K | 0.000 | 0.000 | |
Other liabilities | 2.861 M | 2.740 M | 3.733 M | 3.771 M | 2.083 M | 2.027 M | 13.382 M | 1.032 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 16.268 M | 8.449 M | 16.344 M | 9.593 M | 134.073 K | -4.849 M | -11.384 M | 1.579 M | |
Common stock | 9.562 M | 9.635 M | 10.803 M | 11.432 M | 11.691 M | 12.171 M | 14.098 M | 15.792 M | |
Retained earnings | -387.994 M | -396.249 M | -397.673 M | -404.821 M | -415.536 M | -421.384 M | -425.080 M | -433.516 M |